Insider Transactions in Q2 2025 at New Amsterdam Pharma CO N.V. (NAMS)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2025
|
James N Topper |
BUY
Open market or private purchase
|
Indirect |
1,260
+0.04%
|
$22,680
$18.26 P/Share
|
|
Jun 24
2025
|
James N Topper |
BUY
Open market or private purchase
|
Indirect |
2,520
+0.08%
|
$45,360
$18.43 P/Share
|
|
Jun 16
2025
|
Douglas F Kling Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
100,000
-43.01%
|
$1,900,000
$19.47 P/Share
|
|
Jun 16
2025
|
Douglas F Kling Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+26.11%
|
$1,000,000
$10.45 P/Share
|
|
Jun 16
2025
|
James N Topper |
BUY
Open market or private purchase
|
Indirect |
8,584
+0.28%
|
$163,096
$19.5 P/Share
|
|
Jun 01
2025
|
Louis G Lange |
BUY
Exercise of conversion of derivative security
|
Indirect |
68
+0.24%
|
-
|
|
Jun 01
2025
|
Michael F Marino Iii |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+50.0%
|
-
|
|
May 15
2025
|
Douglas F Kling Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
100,000
-69.44%
|
-
|
|
May 15
2025
|
Douglas F Kling Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+40.98%
|
$1,000,000
$10.0 P/Share
|
|
May 01
2025
|
Louis G Lange |
BUY
Exercise of conversion of derivative security
|
Indirect |
69
+0.24%
|
-
|
|
Apr 15
2025
|
Douglas F Kling Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
100,000
-35.42%
|
-
|
|
Apr 15
2025
|
Douglas F Kling Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+40.98%
|
$1,000,000
$10.0 P/Share
|
|
Apr 15
2025
|
Adele M. Gulfo |
BUY
Grant, award, or other acquisition
|
Direct |
10,860
+50.0%
|
-
|
|
Apr 14
2025
|
Louis G Lange |
BUY
Exercise of conversion of derivative security
|
Indirect |
69
+0.25%
|
-
|